185 related articles for article (PubMed ID: 31877766)
1. The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.
Anan G; Yoneyama T; Noro D; Tobisawa Y; Hatakeyama S; Sutoh Yoneyama M; Yamamoto H; Imai A; Iwamura H; Kohada Y; Mikami J; Ito J; Kaiho Y; Yoneyama T; Hashimoto Y; Sato M; Ohyama C
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877766
[TBL] [Abstract][Full Text] [Related]
2. Quantification of osteopontin in the urine of healthy and stone-forming men.
Yasui T; Fujita K; Hayashi Y; Ueda K; Kon S; Maeda M; Uede T; Kohri K
Urol Res; 1999 Aug; 27(4):225-30. PubMed ID: 10460890
[TBL] [Abstract][Full Text] [Related]
3. Urinary concentration of osteopontin and association with urinary supersaturation and crystal formation.
Tsuji H; Tohru U; Hirotsugu U; Masanori I; Yuji H; Takashi K
Int J Urol; 2007 Jul; 14(7):630-4. PubMed ID: 17645608
[TBL] [Abstract][Full Text] [Related]
4. High calcium concentration and calcium oxalate crystals cause significant inaccuracies in the measurement of urinary osteopontin by enzyme linked immunosorbent assay.
Thurgood LA; Grover PK; Ryall RL
Urol Res; 2008 May; 36(2):103-10. PubMed ID: 18478219
[TBL] [Abstract][Full Text] [Related]
5. Analysis of osteopontin DNA in patients with urolithiasis.
Yamate T; Tsuji H; Amasaki N; Iguchi M; Kurita T; Kohri K
Urol Res; 2000 Jun; 28(3):159-66. PubMed ID: 10929424
[TBL] [Abstract][Full Text] [Related]
6. OPN gene polymorphism (Ala250) and lower serum OPN levels are associated with urolithiasis.
Tugcu V; Simsek A; Tarhan T; Atalar F; Bitkin A; Tasci AI; Kural AR; Altug T
Ren Fail; 2013 Jul; 35(6):825-9. PubMed ID: 23692545
[TBL] [Abstract][Full Text] [Related]
7. Can urine osteopontin levels, which may be correlated with nutrition intake and body composition, be used as a new biomarker in the diagnosis of nephrolithiasis?
Icer MA; Gezmen-Karadag M; Sozen S
Clin Biochem; 2018 Sep; 60():38-43. PubMed ID: 30114399
[TBL] [Abstract][Full Text] [Related]
8. Expression of bone matrix proteins in urolithiasis model rats.
Yasui T; Fujita K; Sasaki S; Sato M; Sugimoto M; Hirota S; Kitamura Y; Nomura S; Kohri K
Urol Res; 1999 Aug; 27(4):255-61. PubMed ID: 10460895
[TBL] [Abstract][Full Text] [Related]
9. Escherichia coli infection induces mucosal damage and expression of proteins promoting urinary stone formation.
Djojodimedjo T; Soebadi DM; Soetjipto
Urolithiasis; 2013 Aug; 41(4):295-301. PubMed ID: 23756638
[TBL] [Abstract][Full Text] [Related]
10. Analysis of urinary concentrations of calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin.
Nishio S; Hatanaka M; Takeda H; Iseda T; Iwata H; Yokoyama M
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S394-6. PubMed ID: 10541271
[TBL] [Abstract][Full Text] [Related]
11. Regulation of osteopontin expression in a rat model of urolithiasis.
Chang L; Feng T; Li J; Dou C; Wei J; Guo Y
Chin Med J (Engl); 2001 Aug; 114(8):829-32. PubMed ID: 11780360
[TBL] [Abstract][Full Text] [Related]
12. Effects of citrate on renal stone formation and osteopontin expression in a rat urolithiasis model.
Yasui T; Sato M; Fujita K; Tozawa K; Nomura S; Kohri K
Urol Res; 2001 Feb; 29(1):50-6. PubMed ID: 11310216
[TBL] [Abstract][Full Text] [Related]
13. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.
Liu CC; Huang SP; Tsai LY; Wu WJ; Juo SH; Chou YH; Huang CH; Wu MT
Clin Chim Acta; 2010 May; 411(9-10):739-43. PubMed ID: 20144595
[TBL] [Abstract][Full Text] [Related]
14. [Changes in the concentration of urolitiasis markers depending on stone-forming activity in patients with recurrent urolithiasis].
Kamalov AA; Okhobotov DA; Nizov AN
Urologiia; 2018 Mar; (1):15-19. PubMed ID: 29634128
[TBL] [Abstract][Full Text] [Related]
15. Renal osteopontin expression in experimental urolithiasis.
Yagisawa T; Chandhoke PS; Fan J; Lucia S
J Endourol; 1998 Apr; 12(2):171-6. PubMed ID: 9607445
[TBL] [Abstract][Full Text] [Related]
16. Relative deficiency of acidic isoforms of osteopontin from stone former urine.
Kolbach AM; Afzal O; Halligan B; Sorokina E; Kleinman JG; Wesson JA
Urol Res; 2012 Oct; 40(5):447-54. PubMed ID: 22322528
[TBL] [Abstract][Full Text] [Related]
17. Distribution of osteopontin and calprotectin as matrix protein in calcium-containing stone.
Tawada T; Fujita K; Sakakura T; Shibutani T; Nagata T; Iguchi M; Kohri K
Urol Res; 1999 Aug; 27(4):238-42. PubMed ID: 10460892
[TBL] [Abstract][Full Text] [Related]
18. Post-translational modification and proteolytic processing of urinary osteopontin.
Christensen B; Petersen TE; Sørensen ES
Biochem J; 2008 Apr; 411(1):53-61. PubMed ID: 18072945
[TBL] [Abstract][Full Text] [Related]
19. Roles of osteopontin gene polymorphism (rs1126616), osteopontin levels in urine and serum, and the risk of urolithiasis: a meta-analysis.
Li X; Liu K; Pan Y; Zhang J; Lv Q; Hua L; Wang Z; Li J; Yin C
Biomed Res Int; 2015; 2015():315043. PubMed ID: 25785266
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the expression of OPN mRNA in the rat as an experimental model of renal stone disease.
Amasaki N; Yamate T; Umekawa T; Ishikawa Y; Kajikawa H; Kurita T
Int J Urol; 1996 Jan; 3(1 Suppl):S88-91. PubMed ID: 24449951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
